Earnings · China A-shares
Zhejiang Dayang Biotech Group Co., Ltd. Class A (003017) earnings
Zhejiang Dayang Biotech Group Co., Ltd. Class A published its Q3 report on 2026-10-25: net profit -14.60% year on year, -14.77% excluding one-off items. Wave Radar's earnings-quality score is 100 of 100 (Sound). The stock moved -2.46% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-25
- Period end
- 2026-09-30
- Net profit YoY
- -14.60%
- Excl. one-offs YoY
- -14.77%
- Net profit QoQ
- -59.10%
- Result
- Neutral
- Quality score
- 100
- Quality
- Sound
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | -2.69% | — |
| 3 days | -2.46% | — |
| 7 days | +2.69% | — |
| 14 days | -0.55% | — |
Report history
Over the last 8 reports, net profit grew year on year in 7 of them. The stock rose in the 3 trading days after 3 of 6 reports (average +0.13%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-26 | ¥68.35M | -14.60% | -14.77% | +6.23% | 0.70 | 5.98% | -2.46% | — | — |
| 2026 interim report | 2026-08-25 | ¥57.47M | +13.79% | +14.93% | +11.93% | 0.59 | 4.94% | +2.62% | +2.55% | +8.57% |
| 2026 Q1 report | 2026-04-28 | ¥30.87M | +5.21% | -4.48% | +11.71% | 0.38 | 2.68% | +0.60% | -16.22% | -15.60% |
| 2025 annual report | 2026-04-28 | ¥99.85M | +56.64% | +51.64% | +14.89% | 1.23 | 9.19% | +0.60% | -16.22% | -15.60% |
| 2025 Q3 report | 2025-10-21 | ¥80.04M | +56.12% | +55.61% | +11.24% | 0.98 | 7.42% | -2.23% | -13.61% | -14.11% |
| 2025 interim report | 2025-08-26 | ¥50.51M | +60.66% | +60.74% | +14.20% | 0.62 | 4.68% | -7.64% | -0.75% | -2.42% |
| 2025 Q1 report | 2025-04-22 | ¥29.34M | +73.44% | +88.88% | +27.78% | 0.36 | 2.76% | +9.89% | +17.10% | +14.24% |
| 2024 annual report | 2025-04-22 | ¥63.75M | +27.48% | +5.94% | -1.03% | 0.78 | 6.30% | +9.89% | +17.10% | +14.24% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.